Stelac Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-6,559	Closed	-$419K	–	115
2023 Q2	$419K	Sell	6,559 -409	-6%	-$27.4K	0.19%	96
2023 Q1	$483K	Buy	6,968 +6	+0.1%	+$423	0.21%	84
2022 Q4	$501K	Sell	6,962 -704	-9%	-$53.1K	0.23%	75
2022 Q3	$546K	Hold	7,666	–	–	0.25%	63
2022 Q2	$590K	Buy	7,666 +4,914	+179%	+$374K	0.24%	59
2022 Q1	$201K	Sell	2,752 -5,163	-65%	-$347K	0.07%	101
2021 Q4	$494K	Sell	7,915 -415	-5%	-$24.3K	0.13%	92
2021 Q3	$493K	Sell	8,330 -326	-4%	-$21.5K	0.13%	115
2021 Q2	$578K	Buy	8,656 +5,058	+141%	+$330K	0.13%	120
2021 Q1	$227K	Sell	3,598 -2,326	-39%	-$145K	0.08%	145
2020 Q4	$367K	Buy	5,924 +2,703	+84%	+$166K	0.09%	129
2020 Q3	$194K	Buy	3,221 +84	+3%	+$5.06K	0.07%	132
2020 Q2	$184K	Buy	+3,137	New	+$188K	0.07%	114
2017 Q4	–	Sell	-1,779	Closed	-$113K	–	69
2017 Q3	$113K	Sell	1,779 -1,130	-39%	-$66K	0.03%	76
2017 Q2	$162K	Hold	2,909	–	–	0.05%	57
2017 Q1	$158K	Buy	2,909 +1,130	+64%	+$62K	0.05%	63
2016 Q4	$104K	Buy	+1,779	New	+$97.3K	0.03%	70